Dr James Wong

Medical Retinal Ophthalmologist MBBS, MMed, FRANZCO

Background

Dr James Wong is a Medical Retina Ophthalmologist and Eye Surgeon, specializing in disorders of the eye including macular degeneration, diabetic retinopathy, central serous chorioretinopathy and cataract surgery.

Dr Wong graduated from the University of Sydney and completed his specialist ophthalmology training at Sydney Eye Hospital gaining Fellowship of the Royal Australian and New Zealand College of Ophthalmologists in 2005. He undertook additional overseas fellowships in the United Kingdom, including a Cataract Surgery and Retina Fellowship at the Royal United Hospital, Bath and subspeciality Medical Retinal and Uveitis Fellowships at the prestigious Moorfields Eye Hospital in London.

Dr Wong has an interest in clinical and basic science research and was awarded a Master of Medicine for laboratory research into inflammatory aspects of macular degeneration. He has presented papers at Australian and international meetings and is a Clinical Lecturer at the University of Sydney.  

Dr Wong is an experienced and respected clinician and is committed to providing patients with access to cutting edge treatments and technology including in clinical trials. He has been principal investigator on multiple international therapeutic trials for macular and retinal disorders for over a decade.

He is also a Consultant Staff Specialist in the Medical Retina Unit at Sydney Eye Hospital and enjoys teaching ophthalmology registrars and Fellows in the outpatient clinic and operating theatre. He is involved regularly with education of medical students, optometrists and general practitioners. He is a member of the Australian and New Zealand Society of Retina Specialists, the American Society of Retina Specialists and American Academy of Ophthalmology.

Dr Wong places a strong emphasis on good communication with patients in order to promote effective health outcomes.

Related Publications

Scientific Journal Publications

Spooner KL, Fraser-Bell S, Hong T, Wong JG, Chang AA. Long-term outcomes of anti-VEGF treatment of retinal vein occlusion. Eye (Lond). 2021 Jun 11.

Read more
Scientific Journal Publications

Ogura Y, Jaffe GJ, Cheung CM, Kokame GT, Iida T, Takahashi K, Lee WK, Chang AA, Monés J, D’Souza D, Weissgerber G. Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK. British Journal of Ophthalmology. 2021 Jul 21.

Read more
Scientific Journal Publications

Jhaveri, C., Wykoff, C.C., Khanani, A.M., Eandi, C.M., Chang, A., Guruprasad, B., Gedif, K.A. and Singer, M., 2021. Early Residual Fluid-free Status and Long-term BCVA outcomes: A Treatment Agnostic, Post-hoc Analysis of Pooled HAWK and HARRIER Data. American Journal of Ophthalmology.

Read more
Scientific Journal Publications

Racic T, Chang A, Fernando N, Brandli A, Natoli R, Penfold P, Provis JM, Rutar M. Anti-inflammatory and neuroprotective properties of the corticosteroid fludrocortisone in retinal degeneration. Exp Eye Res. 2021 Sep 9:108765. doi: 10.1016/j.exer.2021.108765. Epub ahead of print. PMID: 34509498.

Read more

Our Affiliates